Replies to post #121276 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I am thinking that in practice the Parkison's pre-clinical studies funded by MJFF are complete.

The tick in box is likely awaiting the Tue, Nov. 14, 2017, 2:00 PM - 3:00 PM poster presentation by V. FRANCARDO et al. from Lund University Sweden.

http://www.abstractsonline.com/pp8/#!/4376/presentation/28724

It is possible that this pre-clinical study data has in the background is clearing the way for the promised PD P2 trial. Perhaps not with the FDA, but EMA the European Medicines Agency?